Key Therapeutic Insights on Semaglutide in Adolescent Obesity episode artwork

EPISODE · Jan 23, 2023 · 11 MIN

Key Therapeutic Insights on Semaglutide in Adolescent Obesity

from Diabetes Discourse

Host: John Buse, MD, PhD Guest: Silva Arslanian, MD New research on once-daily semaglutide for adolescent patients with obesity may alter clinicians’ approach to care. What do we need to know? Dr. John Buse speaks with one of the study’s investigators, Dr. Silva Arslanian, from the University of Pittsburgh to dive into this clinical data and explore how these results may change the treatment landscape.

Episode metadata supplied by the publisher feed · Published Jan 23, 2023

Embed this episode

NOW PLAYING

Key Therapeutic Insights on Semaglutide in Adolescent Obesity

0:00 11:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 11 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on January 23, 2023.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!